Literature DB >> 33788156

Current Oncologic Standards for Surgery of Small Bowel Cancers.

Nitin Vashistha1, Dinesh Singhal2.   

Abstract

PURPOSE: The last 2 decades has witnessed efforts towards standardization of surgery for small bowel cancers. The proposed recent guidelines/recommendations pertaining to choice of procedure and extent of lymphadenectomy are based on analysis of data from high volume centres of excellence. We evaluated whether these recently proposed oncologic recommendations can be replicated in the setting of single centre/team.
METHODS: This was a retrospective analysis of consecutive adult patients (age ≥ 18 years) who underwent surgery for tumours of small intestine (duodenum, jejunum, and ileum) by the same team of surgeons from 01/01/2010 to 12/31/2019. The procedure performed and lymph nodes harvested during pathologic examination were compared with recent recommendations.
RESULTS: Of the 32 patients (20 males and 12 females), mean age was 52.4 (range 31-77) years. Twenty-nine (90.6%) patients underwent surgery for small bowel cancers. Duodenum was the most common site, while NET was the commonest cancer. Whipple's procedure was performed for tumours of II part of duodenum, while for the rest, segmental resection was performed. The median number of lymph nodes examined for duodenal adenocarcinoma and NET was 14 and 9, respectively. For jejunal/ileal adenocarcinoma, median lymph node number examined was 11.
CONCLUSION: Our study shows that these recently proposed standards for surgery of small bowel cancers are achievable if basic principles of oncologic surgery are followed.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenocarcinoma; Gastrointestinal stromal tumours; Intestine small; Neuroendocrine tumours; Surgery

Year:  2021        PMID: 33788156     DOI: 10.1007/s12029-021-00635-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  1 in total

1.  Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Mary Dillhoff; Eliza Beal; George Poultsides; Eleftherios Makris; Flavio Rocha; Angelena Crown; Kamran Idrees; Paula Marincola Smith; Hari Nathan; Megan Beems; Daniel Abbott; James R Barrett; Ryan C Fields; Jesse Davidson; Kenneth Cardona; Shishir K Maithel
Journal:  JAMA Surg       Date:  2019-02-01       Impact factor: 14.766

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.